Abstract
Background: Characterizing HIV infection and associated risk behaviors within military populations is critical for understanding the epidemic and informing prevention activities. However, the prevalence of HIV and related risk behaviors is often unknown. Further, militaries may not have the systems in place or the staff expertise to conduct HIV surveillance and risk behavior studies.
Methods: The Department of Defense HIV/AIDS Prevention Program (DHAPP), funded by the President’s Emergency Plan for AIDS Relief and the US Department of Defense, provides technical assistance, management and administrative support for HIV/AIDS prevention, care and treatment for approximately 65 partner militaries. Collaborating with partner militaries in conducting Seroprevalence and Behavioral Epidemiology Risk Surveys (SABERS) and using the data to monitor the epidemic and inform activities is a key component of DHAPP. Conclusion: This paper describes the methodology used to plan, adapt, implement and report SABERS studies.Keywords: Military, HIV, methodology, PEPFAR, prevention, sexual risk behaviors, surveillance, uniformed services.
Current HIV Research
Title:Conducting HIV Seroprevalence and Behavioral Epidemiology Risk Surveys (SABERS) Among Partner Military Populations
Volume: 15 Issue: 2
Author(s): Caroline A. Macera*, Stanley I. Ito, Braden R. Hale, Richard A. Shaffer, Anne G. Thomas and Janet Dickieson
Affiliation:
- Department of Defense HIV/AIDS Prevention Program, Naval Health Research Center, 140 Sylvester Road, San Diego, CA 92106-3521,United States
Keywords: Military, HIV, methodology, PEPFAR, prevention, sexual risk behaviors, surveillance, uniformed services.
Abstract: Background: Characterizing HIV infection and associated risk behaviors within military populations is critical for understanding the epidemic and informing prevention activities. However, the prevalence of HIV and related risk behaviors is often unknown. Further, militaries may not have the systems in place or the staff expertise to conduct HIV surveillance and risk behavior studies.
Methods: The Department of Defense HIV/AIDS Prevention Program (DHAPP), funded by the President’s Emergency Plan for AIDS Relief and the US Department of Defense, provides technical assistance, management and administrative support for HIV/AIDS prevention, care and treatment for approximately 65 partner militaries. Collaborating with partner militaries in conducting Seroprevalence and Behavioral Epidemiology Risk Surveys (SABERS) and using the data to monitor the epidemic and inform activities is a key component of DHAPP. Conclusion: This paper describes the methodology used to plan, adapt, implement and report SABERS studies.Export Options
About this article
Cite this article as:
Macera A. Caroline*, Ito I. Stanley , Hale R. Braden , Shaffer A. Richard, Thomas G. Anne and Dickieson Janet , Conducting HIV Seroprevalence and Behavioral Epidemiology Risk Surveys (SABERS) Among Partner Military Populations, Current HIV Research 2017; 15 (2) . https://dx.doi.org/10.2174/1570162X15666170516164521
DOI https://dx.doi.org/10.2174/1570162X15666170516164521 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
Management of HIV: Management of HIV: old challenges and new needs
The aim of this thematic issue is to provide the most recent updates regarding the effective management of HIV infection. Antiretroviral therapy (ART) has significantly decreased HIV-related mortality, leading to an enhancement in the quality of life and life expectancy for people living with HIV (PLWH). Despite the numerous advancements ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
DNA Methyltransferase-1 Inhibitors as Epigenetic Therapy for Cancer
Current Cancer Drug Targets Editorial [Hot Topic: Cyclooxygenases and Cyclooxygenase Inhibitors in Neurological and Psychiatric Diseases (Executive Editor: Luisa Minghetti) ]
Current Pharmaceutical Design The Contribution of Dopamine to the Implementation of Reward Value During the Control of Action
Central Nervous System Agents in Medicinal Chemistry Protease-Activated Receptors as Therapeutic Targets in Visceral Pain
Current Neuropharmacology Management of Vasculopathy in Connective Tissue Disease
Current Rheumatology Reviews Blockers of Voltage-Gated Sodium Channels for the Treatment of Central Nervous System Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Cholecystokinin Antagonists A New Way to Improve the Analgesia from Old Analgesics?
Current Pharmaceutical Design In Vitro and In Vivo Experimental Model-based Approaches for Investigating Anti-inflammatory Properties of Coumarins
Current Medicinal Chemistry Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System
CNS & Neurological Disorders - Drug Targets N-Acetylcysteine for the Treatment of Obsessive-Compulsive Disorder
Current Psychiatry Reviews Screening Haemostasis – Looking for Global Assays: The Overall Haemostasis Potential (OHP) Method – A Possible Tool for Laboratory Investigation of Global Haemostasis in Both Hypo- and Hypercoagulable Conditions
Current Vascular Pharmacology Nutritional Overview on the Management of Type 2 Diabetes and the Prevention of its Complications
Current Diabetes Reviews Patent Review on Network-based Elderly Healthcare System in the US
Recent Patents on Computer Science New Drugs from Old Natural Compounds: Scarcely Investigated Sesquiterpenes as New Possible Therapeutic Agents
Current Medicinal Chemistry Neurotoxicity of Insecticides
Current Medicinal Chemistry Micropropagation: A Tool for the Production of High Quality Plant-based Medicines
Current Pharmaceutical Biotechnology Tandem Repeat Peptide Strategy for the Design of Neurotrophic Factor Mimetics
CNS & Neurological Disorders - Drug Targets Protein-Protein Interactions and Subunit Composition of Ion Channels
CNS & Neurological Disorders - Drug Targets Potential Use of Nanomedicine for the Anti-inflammatory Treatment of Neurodegenerative Diseases
Current Pharmaceutical Design